Trading Members of the Exchange are hereby informed that effective from December 23, 2015, the equity shares of Dr. Lal PathLabs (Scrip Code: 539524) are listed and admitted to dealings on the Exchange in the list of B Group Securities.
The above information is a part of company’s filings submitted to BSE.